Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models

BACKGROUND: Pancreatic Ductal Adenocarcinoma (PDAC) is a highly aggressive malignancy with only a 5% 5-year survival rate. Reliable biomarkers for early detection are still lacking. The goals of this study were (a) to identify early humoral responses in genetically engineered mice (GEM) spontaneousl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Capello, Michela, Cappello, Paola, Linty, Federica Caterina, Chiarle, Roberto, Sperduti, Isabella, Novarino, Anna, Salacone, Paola, Mandili, Giorgia, Naccarati, Alessio, Sacerdote, Carlotta, Beghelli, Stefania, Bersani, Samantha, Barbi, Stefano, Bassi, Claudio, Scarpa, Aldo, Nisticò, Paola, Giovarelli, Mirella, Vineis, Paolo, Milella, Michele, Novelli, Francesco
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3844582/
https://ncbi.nlm.nih.gov/pubmed/24010981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-67
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados